ÂÜÀòÂÒÂ×

Ulrike Fiedler has held a variety of roles in the biotechnology industry since 1996. Ulrike began their career as a Postdoctoral Fellow in Molecular Biology and Biochemistry at the Institute for Molecular Oncology, Tumor Biology Center Freiburg in 2000. In 2001, they were promoted to Group Leader at the same institution. In 2007, they moved to ProQinase as a Senior Scientist. From 2010 to 2020, they worked at Molecular Partners AG, Zurich, Switzerland, first as a VP Oncology Research and then as a Principal Scientist. Ulrike currently serves as a Senior Director Program Management and Pipeline Innovation at NBE-Therapeutics AG.

Ulrike Fiedler obtained a Diploma in Biology from the Department of Molecular Microbiology at the University of Konstanz, Germany in 1993. Ulrike then went on to pursue a Doctor of Philosophy (Ph.D.) in Biology at the same department, which they completed in 2006.